Futura Genetics Overview
Futura Genetics is a digital health platform powered by genomic data and developed for life insurance issuers and their clients. The company offers life insurers effective, personalized tools designed to extend their customers' life expectancies, thereby increasing retention and decreasing claims. In addition, the company provides life insurance clients with a gamified personalized experience that uses their personal DNA to motivate them to be proactive about their health. The system aims to help life insurance clients become more engaged and live longer, healthier lives. Futura Genetics' partners include several American insurance companies, Hadassah Ein Kerem Hospital, and DNA-sequencing giant Illumina.
Cumulative Funding Raised Over Time ($)
—Jan 2021
Latest News
growth-positive
Preventive Medicine for All
Futura Genetics, a company focused on preventative medicine through genetic testing, is partnering with insurance companies to offer non-invasive home genetic tests and counseling to insured individuals. The test results are not shared with the insurance company, ensuring that premiums do not increase as a result. Futura Genetics has successfully completed a pilot program with a large insurance company and plans to launch another funding round in the summer. The companys partners include American insurance companies, Hadassah Ein Kerem Hospital, and DNA sequencing company Illumina.
CustomersPartnersInvestment
growth-positive
Futura Genetics Launches a Disruptive Genetic-Based Platform to Provide Medical Guidance for Life Insurance Clients - JLM-BioCity
Futura Genetics has launched a free preventive care program that offers a non-invasive DNA test to assess the risk of developing chronic diseases. The program is being offered by life and health insurance companies to their clients, as it helps extend their customers lives and reduces insurance claims. Futura Genetics uses genetic testing and precision medicine techniques to create personalized preventive care programs for individuals. The program motivates users to perform tasks that improve their health and offers rewards for their efforts. The company recently completed a successful pilot program with an international insurance company, showing a high return on investment. Futura Genetics is focused on revolutionizing the healthcare industry by providing effective tools for insurers to prolong their customers life expectancy.
Customers
growth-positive
More Information About Diseases Risk from Your 23andMe Data
Futura Genetics has launched a unique DNA test for 23andMe report data users, allowing them to discover their disease risk results within minutes. The company specializes in detecting genetic SNPs linked to an increased risk of developing common and deadly diseases. The test provides a detailed report that identifies the presence of these health risks, enabling early detection and prevention. Futura Genetics believes that this new testing possibility will help people avoid illness and live a healthier lifestyle. The analysis of 23andMe test results can now be done without the need for additional testing. The test and supplementary information are available on the Futura Genetics website.
Customers
growth-positive
Genome sequencing: unlocking personalised medicine
The article discusses the progress and potential of whole genome sequencing in personalized medicine. It highlights companies like Futura Genetics, Oxford Nanopore, Counsyl, and Veritas Genetics that offer genome sequencing services for individuals to assess their genetic risks and receive lifestyle recommendations. The article suggests that while whole genome sequencing has become more accessible and affordable, personalized medicine still has a long way to go. Current treatments are based on standard care, which may not be effective for all patients. The article emphasizes the need for truly personalized treatments based on an individuals genetic makeup. Whole genome sequencing is seen as a tool to guide the development of personalized treatments in the future.
Customers
Futura Genetics Analyzed my Genome - Genetic Test Review - The Medical Futurist
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 2 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.futuragenetics.com |
Locations
Tel Aviv, Israel
Photos & Videos
1 item(s)
Futura Genetics Business
Business models
B2B2C
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesDigital HealthcareClinical WorkflowFintech & InsurtechInsurtechTarget Customer
Healthcare & Life SciencesHealthcareInsurance CompaniesPatientsCore Technology
Platforms & InterfacesSoftwareArtificial IntelligenceTags (14)
digital-healthcaremonitoringpersonalizationtestingartificial-intelligencenon-invasiveinsurtechsoftware-applicationsinsurance-companiesgenomicsclinical-workflowgamificationhealthcare-providerspatientsGeographic Markets
AsiaAmericasEuropeNorth AmericaFutura Genetics Financials
Undisclosed
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Seed
Funding stage
1
Total rounds
2
Investors
Cumulative Funding Raised Over Time ($)
—Jan 2021
Private Equity Funding
Undisclosed Round
Jan 2021
Undisclosed
GoAhead Ventures (Lead)
,
Avishag Bohbot
Futura Genetics Lifecycle
Cumulative Funding Raised Over Time
—Jan 2021
All Events
Undisclosed Round
Jan 2021
Undisclosed
GoAhead Ventures (Lead)
,
Avishag Bohbot
Futura Genetics News
6 articles
growth-positive
Preventive Medicine for All
Futura Genetics, a company focused on preventative medicine through genetic testing, is partnering with insurance companies to offer non-invasive home genetic tests and counseling to insured individuals. The test results are not shared with the insurance company, ensuring that premiums do not increase as a result. Futura Genetics has successfully completed a pilot program with a large insurance company and plans to launch another funding round in the summer. The companys partners include American insurance companies, Hadassah Ein Kerem Hospital, and DNA sequencing company Illumina.
CustomersPartnersInvestment
growth-positive
Futura Genetics Launches a Disruptive Genetic-Based Platform to Provide Medical Guidance for Life Insurance Clients - JLM-BioCity
Futura Genetics has launched a free preventive care program that offers a non-invasive DNA test to assess the risk of developing chronic diseases. The program is being offered by life and health insurance companies to their clients, as it helps extend their customers lives and reduces insurance claims. Futura Genetics uses genetic testing and precision medicine techniques to create personalized preventive care programs for individuals. The program motivates users to perform tasks that improve their health and offers rewards for their efforts. The company recently completed a successful pilot program with an international insurance company, showing a high return on investment. Futura Genetics is focused on revolutionizing the healthcare industry by providing effective tools for insurers to prolong their customers life expectancy.
Customers
growth-positive
More Information About Diseases Risk from Your 23andMe Data
Futura Genetics has launched a unique DNA test for 23andMe report data users, allowing them to discover their disease risk results within minutes. The company specializes in detecting genetic SNPs linked to an increased risk of developing common and deadly diseases. The test provides a detailed report that identifies the presence of these health risks, enabling early detection and prevention. Futura Genetics believes that this new testing possibility will help people avoid illness and live a healthier lifestyle. The analysis of 23andMe test results can now be done without the need for additional testing. The test and supplementary information are available on the Futura Genetics website.
Customers
growth-positive
Genome sequencing: unlocking personalised medicine
The article discusses the progress and potential of whole genome sequencing in personalized medicine. It highlights companies like Futura Genetics, Oxford Nanopore, Counsyl, and Veritas Genetics that offer genome sequencing services for individuals to assess their genetic risks and receive lifestyle recommendations. The article suggests that while whole genome sequencing has become more accessible and affordable, personalized medicine still has a long way to go. Current treatments are based on standard care, which may not be effective for all patients. The article emphasizes the need for truly personalized treatments based on an individuals genetic makeup. Whole genome sequencing is seen as a tool to guide the development of personalized treatments in the future.
Customers
Futura Genetics Analyzed my Genome - Genetic Test Review - The Medical Futurist
growth-positive
Futura Genetics DNA Test Measures Risk For 28 Health Conditions
The article discusses the benefits and process of at-home DNA testing offered by Futura Genetics. The company has 15 years of experience in the field of DNA testing and provides a test kit that measures the risk of developing 28 common conditions. Customers can order the test kit online, provide a saliva sample, and receive a report with their risk percentile for each condition. The article emphasizes that genetic testing is a tool to make informed health decisions and that lifestyle choices also play a significant role in overall health. The impact on the company is growth-positive as it highlights the increasing demand for at-home DNA testing kits.
Customers
Futura Genetics Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 3 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 13 classification IDs that could be used for matching.
Futura Genetics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 99/100 |
| Missing | markets |
| BI Verification | Tzippora Nusbaum |
| Registrar ID | 515883247 |
| Crunchbase | futura-genetics |
| Creator | Svitlana Panchuk |
| Creator email | psi.lana12@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-04-12T00:00:00.000Z |
| Created | 2018-10-16T00:00:00.000Z |
| Claimed | Yes |